Search
for
Sort by
Research 841–870 of 1000+
- Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure.
- Classification and management of skin, hair, nail and mucosal side-effects of epidermal growth factor receptor (EGFR) inhibitors
- Mice humanised for the EGF receptor display hypomorphic phenotypes in skin, bone and heart
- Growth Factor and Growth Factor Receptor Localization in the Hair Follicle Bulge and Associated Tissue in Human Fetus
- The PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) syndrome
- Epidermal Growth Factor Induces Proliferation of Hair Follicle-Derived Mesenchymal Stem Cells Through Epidermal Growth Factor Receptor-Mediated Activation of ERK and AKT Signaling Pathways Associated with Upregulation of Cyclin D1 and Downregulation of p16
- Targeting the pre-receptor metabolism of cortisol as a novel therapy in obesity and diabetes
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- Palmitoylethanolamide Stimulation Induces Allopregnanolone Synthesis in C6 Cells and Primary Astrocytes: Involvement of Peroxisome-Proliferator Activated Receptor-α
- Dermatological side effects of epidermal growth factor receptor inhibitors: ′Pride′ complex
- Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors
- Nonsteroidal tissue selective androgen receptor modulators: a promising class of clinical candidates
- Lichen planopilaris treated by the peroxisome proliferator activated receptor-γ agonist pioglitazone: Lack of lasting improvement or cure in the majority of patients
- A case report of inflammatory nonscarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib
- Scarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib
- Glucagon-like peptide-1 receptor agonist medications and hair loss: A retrospective cohort study
- Ligand‐independent epidermal growth factor receptor hyperactivation increases sebaceous gland size and sebum secretion in mice
- Role for the Epidermal Growth Factor Receptor in Chemotherapy-Induced Alopecia
- Peroxisome proliferator-activated receptor-γ signalling protects hair follicle stem cells from chemotherapy-induced apoptosis and epithelial–mesenchymal transition
- Regulation of Hair Shedding by the Type 3 IP3 Receptor
- Treatment of Epidermal Growth Factor Receptor Inhibitor-Induced Acneiform Eruption with Topical Recombinant Human Epidermal Growth Factor
- The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors
- Perifollicular Xanthomas Associated with Epidermal Growth Factor Receptor Inhibitor Therapy
- Loss‐of‐function of Endothelin receptor type A results in Oro‐Oto‐Cardiac syndrome
- The epidermal growth factor receptor decreases Stathmin 1 and triggers catagen entry in the mouse
- Potential Involvement of the Stem Cell Factor Receptor c-kit in Alopecia Areata and Androgenetic Alopecia: Histopathological, Immunohistochemical, and Semiquantitative Investigations
- Epidermal Growth Factor Receptor Inhibitors: Cutaneous Side Effects and Their Management.
- Histopathologic features of erythematous papulopustular eruption to epidermal growth factor receptor inhibitors in cancer patients